![](https://endpts.com/wp-content/uploads/2024/07/Peter-Lebowitz-Third-Arc-Bio-feature.jpg)
Peter Lebowitz, Third Arc Bio CEO
At Third Arc Bio, former J&J leaders raise $165M to test oncology, autoimmune biologics
After more than a decade steering Johnson & Johnson’s oncology drug R&D, Peter Lebowitz is ready for his next challenge: shepherding the …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.